Just do a very rough calculation. Let's just assume all cash AUD105m(after CR) are for trial, total around 1200 patients, cost per head is AUD87500. The average cost searched online for phase 3 is USD41117, take the inflation 10% incurred over last year, USD45228, converted to AUD63855. I guess funds should be sufficient to cover cost? Definitely it depends on how efficiently they run the trial and if there is any extra large expenses incurred.
Ann: Trading Halt, page-131
-
- There are more pages in this discussion • 146 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.5¢ |
Change
0.005(1.92%) |
Mkt cap ! $92.69M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.0¢ | 25.5¢ | $233.3K | 883.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 18279 | 26.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.0¢ | 1025 | 2 |
View Market Depth
| Last trade - 14.51pm 28/06/2024 (20 minute delay) ? |
| PAR (ASX) Chart |